Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazem (Q40122896)

17 September 2017

title

Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem (English)

1 reference

17 September 2017

Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazem (English)

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

8 September 2023

1 reference

1 reference

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

8 September 2023

author name string

P. D. Henry

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6255787

8 September 2023

publication date

1 December 1980

1 reference

https://api.elsevier.com/content/article/PII:0002914980903665?httpAccept=text/xml

17 September 2017

language of work or name

English

0 references

work available at URL

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

https://api.elsevier.com/content/article/PII:0002914980903665?httpAccept=text/plain

8 September 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

American Journal of Cardiology

8 September 2023

published in

1 reference

17 September 2017

volume

46

1 reference

17 September 2017

issue

6

1 reference

17 September 2017

page(s)

1047-1058

1 reference

publication type of scholarly work

17 September 2017

review article

1 reference

CORONARY VASODILATORY AND CARDIAC ADRENERGIC BLOCKING EFFECTS OF IPROVERATRIL

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Specific Pharmacology of Calcium in Myocardium, Cardiac Pacemakers, and Vascular Smooth Muscle

8 September 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Effects of D 600 and papaverine on the inotropic response to isoprenaline on left guinea-pig atria under the graded influence of changes of frequency and temperature

8 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Effect of diazoxide, verapamil and compound D600 on isoproterenol and calcium-mediated dose-response relationships in isolated rabbit atrium

8 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Improvement of tissue perfusion with inhibitors of calcium ion influx

8 September 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Factors controlling cytoplasmic Ca 2+ concentration

8 September 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Effects of some vasodilators on calcium translocation in intact and fractionated vascular smooth muscle

8 September 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Hypotensive action of N-ethoxycarbonyl3-morpholinosydnonimine, SIN-10

8 September 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

The role of calcium antagonism in the therapeutic action of drugs

8 September 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Ionic basis of electrical activity in cardiac tissues

8 September 2023

25

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Ionic channels in excitable membranes. Current problems and biophysical approaches

8 September 2023

26

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Gating currents and charge movements in excitable membranes

8 September 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Cardiac Purkinje fibres: [Ca2+]i controls steady state potassium conductance

8 September 2023

28

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Tetrodotoxin and Manganese Ion: Effects on Action Potential of the Frog Heart

8 September 2023

29

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Sites of action and active forms of lidocaine and some derivatives on cardiac Purkinje fibers

8 September 2023

30

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Existence and role of a slow inward current during the frog atrial action potential

8 September 2023

31

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Exchange of calcium ions in the mammalian myocardium. Mechanisms and physiological significance

8 September 2023

32

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Uncoupling cation effects on cardiac contractility and sarcolemmal Ca2+ binding

8 September 2023

33

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

The effects of nifedipine on contraction and monophasic action potential of isolated cat myocardium

8 September 2023

35

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Inhibition of the slow inward current by nifedipine in mammalian ventricular myocardium

8 September 2023

37

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Inotropic and electrophysiological actions of verapamil and D 600 in mammalian myocardium. III. Effects of the optical isomers on transmembrane action potentials

8 September 2023

38

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Relationship of antiarrhythmic to inotropic activity and antiarrhythmic qualities of the optical isomers of verapamil

8 September 2023

40

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Reversible Inhibition of Potassium Contractures by optical isomers of verapamil and D 600 on slow muscle fibres of the frog

8 September 2023

41

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

On the mechanism underlying the action of D-600 on slow inward current and tension in mammalian myocardium

8 September 2023

42

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Differentiation of the transmembrane Na and Ca channels in mammalian cardiac fibres by the use of specific inhibitors

8 September 2023

43

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Multiple effects of calcium antagonists on plateau currents in cardiac Purkinje fibers

8 September 2023

44

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Kinetics of inactivation and recovery of the slow inward current in the mammalian ventricular myocardium

8 September 2023

45

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Electrophysiologic effects of diltiazem, a new slow channel inhibitor, on canine cardiac fibers

8 September 2023

46

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Effects of calcium-antagonistic coronary vasodilators on myocardial contractility and membrane potentials

8 September 2023

47

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Effect of Diltiazem on Electrical and Mechanical Activity of Isolated Cardiac Ventricular Muscle of Guinea Pig

8 September 2023

48

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Differential effects of adenosine and nitroglycerin on the action potentials of large and small coronary arteries

8 September 2023

49

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Effects of Coronary Vasodilators on Large and Small Coronary Arteries of Dogs

8 September 2023

50

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

A study of compounds which inhibit vascular smooth muscle contraction

8 September 2023

51

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Verapamil and nifedipine inhibition of contractions induced by potassium and noradrenaline in human mesenteric arteries and veins

8 September 2023

54

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Structure-activity studies on nifedipine in isolated cardiac muscle

8 September 2023

55

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Investigations on the structure-activity relationships of verapamil

8 September 2023

56

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Gas chromatographic determination of nifedipine and one of its metabolites using electron capture detection

8 September 2023

57

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Physiological disposition of verapamil in man

8 September 2023

59

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

The metabolism of DL-[14C]verapamil in man

8 September 2023

60

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Pharmacokinetics of verapamil in man

8 September 2023

61

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Electrophysiologic and hemodynamic effects of verapamin. Correlation with plasma drug concentrations

8 September 2023

62

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Pharmacokinetics and bioavailability of diltiazem (CRD-401) in dog

8 September 2023

63

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Hemodynamic effects caused by i.v. administration of verapamil in healthy subjects

8 September 2023

66

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

The Effect of a Calcium-antagonistic Drug, Nifedipine, on the Mechanical and Electrical Activity of the Isolated Rat Atrium

8 September 2023

68

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

On the action of nifedipine under conditions of variable stimulation patterns and [Ca2+]0 in guinea-pig atrium

8 September 2023

69

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Effects of nifedipine on coronary and systemic hemodynamics in the conscious dog

8 September 2023

72

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Differences in the cardiac actions of the calcium antagonists verapamil and nifedipine

8 September 2023

76

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Effects of atrio-ventricular conduction of calcium-antagonistic coronary vasodilators, local anaesthetics and quinidine injected into the posterior and the anterior septal artery of the atrio-ventricular node preparation of the dog.

8 September 2023

77

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Effect of nifedipine on atrioventricular conduction as compared with verapamil. Intracardiac electrophysiological study

8 September 2023

78

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Effects of verapamil on myocardial performance in coronary disease

8 September 2023

81

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Haemodynamic effects of a new anti-anginal drug, diltiazem hydrochloride

8 September 2023

82

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Editorial: "Variant" angina pectoris

8 September 2023

84

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Prinzmetal's variant form of angina pectoris. Re-evaluation of mechanisms

8 September 2023

85

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Pathogenesis and treatment of angina pectoris at rest as seen from its response to various drugs

8 September 2023

86

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Panel discussion on the variant form of angina pectoris

8 September 2023

87

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Exertional angina pectoris caused by coronary arterial spasm: Effects of various drugs

8 September 2023

89

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Circadian variation of exercise capacity in patients with Prinzmetal's variant angina: role of exercise-induced coronary arterial spasm

8 September 2023

90

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Coronary arterial spasm and Prinzmetal's variant form of angina induced by hyperventilation and Tris-buffer infusion

8 September 2023

91

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Suppression of repeatedly occurring ventricular fibrillation with nifedipine in variant form of angina pectoris

8 September 2023

92

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Nifedipine in the Treatment of Life Threatening Prinzmetal Angina

8 September 2023

93

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Effect of verapamil studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia

8 September 2023

95

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Haemodynamic effects of supraventricular tachycardias and their alterations by electrically and verapamil induced termination

8 September 2023

96

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Verapamil: a review of its pharmacological properties and therapeutic use.

8 September 2023

97

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Effect of drugs on conduction delay and incidence of ventricular arrhythmias induced by acute coronary occlusion in dogs

8 September 2023

98

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Effects of verapamil on ventricular rhythm during acute coronary occlusion

8 September 2023

99

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Reentrant ventricular arrhythmias in the late myocardial infarction period. 7. Effect of verapamil and D-600 and the role of the "slow channel"

8 September 2023

100

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

A study on the effects of nifedipine in hypertensive crises and severe hypertension

8 September 2023

101

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Nifedipine, a new antihypertensive with rapid action

8 September 2023

102

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Does verapamil have a clinically significant antihypertensive effect?

8 September 2023

104

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Effects of nifedipine on myocardial perfusion and ischemic injury in dogs

8 September 2023

105

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Effect of nifedipine on myocardial ischemia: analysis of collateral flow, pulsatile heat and regional muscle shortening

8 September 2023

106

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Regional contractility. Selective depression of ischemic myocardium by verapamil

8 September 2023

107

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Effect of the calcium antagonist verapamil on necrosis following temporary coronary artery occlusion in dogs

8 September 2023

108

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Myocardial contracture and accumulation of mitochondrial calcium in ischemic rabbit heart

8 September 2023

109

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

The effect of -adrenoceptor and Ca2+ antagonist drugs on the hypoxia-induced increase in resting tension

8 September 2023

110

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Pharmacological preservation of the ischemic heart

8 September 2023

111

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Therapeutic trials in hamster dystrophy

8 September 2023

112

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Treatment of hypertrophic obstructive cardiomyopathy with verapamil, a calcium antagonist (author's transl)

8 September 2023

113

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects

8 September 2023

114

1 reference

https://api.crossref.org/works/10.1016/0002-9149(80)90366-5

8 September 2023

Identifiers

1 reference

17 September 2017

1 reference